NCT04810195View on ClinicalTrials.gov

Early neo2 Registry of the Acurate neo2 TAVI Prosthesis

CompletedOBSERVATIONAL
Enrollment

554

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

April 1, 2021

Study Completion Date

March 15, 2022

Conditions
Aortic Valve Stenosis
Interventions
DEVICE

Boston Scientific Acurate neo2 TAVR device

The newest generation of the Acurate neo2 TAVR device, launched in Europe in 2020.

Trial Locations (4)

Unknown

Rigshospitalet, Copenhagen

Kerckhoff Klinik, Bad Nauheim

Lund University Hospital, Lund

Karolinska University Hospital, Stockholm

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Andreas Rück

OTHER